Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1907 studies found for:    Open Studies | "Drug Therapy"
Show Display Options
Rank Status Study
21 Recruiting Mechanisms and Predictors of Unusual Radiation or Chemotherapy Toxicity
Condition: Severe or Mild Toxicity From Radiotherapy and/or Chemotherapy
Intervention: Other: Blood Draw
22 Recruiting Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV
Condition: Gastric Cancer, Adjuvant Chemotherapy, XO
Interventions: Drug: Docetaxel and capecitabine and oxaliplatin;   Drug: capecitabine and oxaliplatin
23 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
24 Not yet recruiting Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: only antiemetic (Ramosetron, Tropisetron and dexamethasone);   Other: Matching points ST36+CV12 plus antiemetic drug;   Other: Matching points PC6+CV12 plus antiemetic drug;   Other: Matching points CV13+CV12 plus antiemetic drug
25 Not yet recruiting The Efficacy of Surgical Treatment in Combinations With Intraperitoneal Immunotherapy (With Interleykin-2 - Human Cytokine Reaction Activator) and Systemic Chemotherapy in Patients With Gastric Cancer and Verified Free Cancer Cells
Condition: Combined Treatment of Advanced Gastric Cancer Immunotherapy, Systemic Chemotherapy, Downstaging of Gastric Cancer
Intervention: Drug: intraperitoneal immunotherapy with interleykin-2 plus systemic chemotherapy
26 Recruiting Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training
Conditions: Exercise;   Chemotherapy-induced Polyneuropathy
Intervention: Behavioral: Exercise
27 Not yet recruiting Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy
Conditions: Chemotherapy-Induced Nausea and Vomiting;   Lung Cancer
Interventions: Drug: Aprepitant;   Drug: Palonosetron;   Drug: Dexamethasone
28 Not yet recruiting A 6 microRNA Tool for Stratifying Stage II Colon Cancer of Receiving Adjuvant Chemotherapy
Conditions: Colonic Neoplasms;   Effects of Chemotherapy
Interventions: Other: A 6 microRNA stratified tool;   Other: A classic stratified tool
29 Recruiting Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer
Conditions: Precision Cell Immunotherapy;   Chemotherapy;   Advanced Lung Cancer
Interventions: Drug: Chemotherapy;   Biological: Precision Cells
30 Not yet recruiting Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma
Conditions: Small Bowel Adenocarcinoma;   Adjuvant Chemotherapy for SBA
Interventions: Drug: observation alone;   Drug: LV5FU2;   Drug: FOLFOX
31 Recruiting Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
Conditions: Precision Cell Immunotherapy;   Chemotherapy;   Advanced Gastric Cancer
Interventions: Drug: Chemotherapy;   Biological: Precision Cell Immunotherapy
32 Recruiting Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
Conditions: Precision Cell Immunotherapy;   Chemotherapy;   Advanced Malignancies
Interventions: Drug: Chemotherapy;   Biological: Precision Cells
33 Not yet recruiting Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer
Conditions: Chemotherapy-induced Nausea and Vomiting;   Colorectal Cancer
Interventions: Drug: Aprepitant+Tropisetron;   Drug: Dexamethasone+Tropisetron
34 Recruiting Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33
Conditions: Relapsed Adult Myeloid Leukemia;   Chemotherapy Refractory Adult Myeloid Leukemia
Interventions: Biological: CART33 cells;   Biological: anti-CD33 CART;   Biological: anti-CD33 CAR T cells
35 Recruiting Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
Condition: Chemotherapy-induced Neutropenia
Interventions: Drug: HSA-GCSF 1.2 mg;   Drug: HSA-GCSF 1.5 mg;   Drug: GCSF
36 Not yet recruiting Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Conditions: Breast Cancer;   Chemotherapy Induced Amenorrhea;   Ovarian Function Suppression
Interventions: Drug: Goserelin;   Drug: Toremifene
37 Recruiting Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
Condition: Chemotherapy-Induced Neutropenia
Intervention: Biological: Nivestim®
38 Recruiting Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia
Conditions: Chemotherapy-Induced Neutropenia;   Myelosuppression;   Breast Cancer
Interventions: Drug: Myelo001;   Drug: Placebo
39 Recruiting Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients
Condition: Chemotherapy-induced Nausea and Vomiting
Intervention: Drug: Palonosetron, ondansetron, dexamethasone
40 Recruiting PhysioFlow to Detect Cardiotoxicity in Chemo
Condition: Chemotherapy, Cancer, Cardiotoxicity, Physioflow
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.